Neurofibromatosis type 2 in childhood: a clinical characterization

被引:1
|
作者
Hinojosa-Mateo, Carmen M. [1 ]
Reche-Sainz, Jose A. [2 ]
Hernandez-Nunez, Almudena [3 ]
Ramos-Lopez, Maria [4 ]
Arpa-Fernandez, Ana [5 ]
Natera-de Benito, Daniel [1 ]
机构
[1] Hosp Univ Fuenlabrada, Serv Pediat, Camino Molino 2, E-28942 Madrid, Spain
[2] Hosp Univ Fuenlabrada, Serv Oftalmol, Madrid, Spain
[3] Hosp Univ Fuenlabrada, Serv Dermatol, Madrid, Spain
[4] Hosp Univ Fuenlabrada, Serv Radiol, Madrid, Spain
[5] Hosp Univ Fuenlabrada, Serv Lab Clin, Madrid, Spain
关键词
Childhood; Congenital cataract; Meningioma; Neurofibromatosis type 2; Schwannoma; Wishart; DIAGNOSIS; MANAGEMENT; NF2;
D O I
10.33588/rn.6403.2016355
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Neurofibromatosis type 2 (NF2) is a dominantly inherited neuroectodermal syndrome that predispose to the development of tumors of the central and peripheral nervous system. Additional features include eye and skin abnormalities. Case report. A 12-year old male with diagnosis of MF2 according to Baser et al and presentation in childhood was included. A comprehensive bibliographic review of evolution of the diagnostic criteria for NF2 in children was performed. Conclusions. The pattern of presentation of NF2 in childhood differs from adulthood in many aspects. Ophthalmologic and skin manifestations, and not an auditory dysfunction, are the most common initial symptoms in prepuberal-onset NF2. The most frequent symptoms and signs at presentation are posterior subcapsular cataract, skin manifestations as NF2 plaques and/ or peripheral nerve tumors, and neurological dysfunction related to isolated or multiple cranial nerve deficits (other than nerve VIII), brainstem masses or spinal masses. As sensitivity of diagnostic criteria in children is low, those prepuberal patients with congenital or early-onset cataracts and typical skin manifestations of NF2 should be systematically assessed.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 50 条
  • [31] Role of Molecular Genetic Factors in Formation of the Clinical Type of Neurofibromatosis Type 2
    Karandasheva, K. O.
    Makashova, E. S.
    Ageeva, F. A.
    Anoshkin, K. I.
    Sparber, P. A.
    Borovikov, A. O.
    Vasiluev, P. A.
    Pashchenko, M. S.
    Tanas, A. S.
    Strelnikov, V. V.
    RUSSIAN JOURNAL OF GENETICS, 2024, 60 (02) : 210 - 219
  • [32] Neurofibromatosis Type 2
    Slattery, William H.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2015, 48 (03) : 443 - +
  • [33] Neurofibromatosis type 2
    Vallejo, Manuel C.
    Jordan, Matthew P.
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2015, 56 : S675 - S681
  • [34] NEUROFIBROMATOSIS TYPE 2
    Kalamarides, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 630 - 630
  • [35] Neurofibromatosis type 2
    Asthagiri, Ashok R.
    Parry, Dilys M.
    Butman, John A.
    Kim, H. Jeffrey
    Tsilou, Ekaterini T.
    Zhuang, Zhengping
    Lonser, Russell R.
    LANCET, 2009, 373 (9679): : 1974 - 1986
  • [36] Neurofibromatosis type 2
    Evans, DGR
    Sainio, M
    Baser, ME
    JOURNAL OF MEDICAL GENETICS, 2000, 37 (12) : 897 - 904
  • [37] Neurofibromatosis type 2
    Sathornsumetee, S.
    DesJardins, A.
    Reardon, D. A.
    Rich, J. N.
    Vredenburgh, J. J.
    NEUROLOGY, 2007, 68 (13) : E14 - E14
  • [38] Neurofibromatosis type 2
    Perez-Grau, Marta
    Miro, Nuria
    Prades, Jose
    Verges, Juan
    Lareo, Susana
    Roca-Ribas, Francesc
    ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2010, 61 (04): : 306 - 311
  • [39] Neurofibromatosis type 2
    Caldemeyer, KS
    Mirowski, GW
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (05) : 744 - 745
  • [40] Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2 Clinical article
    Choi, Jung Won
    Lee, Ji Yeoun
    Phi, Ji Hoon
    Wang, Kyu-Chang
    Chung, Hyun-Tai
    Paek, Sun Ha
    Kim, Dong Gyu
    Park, Sung-Hye
    Kim, Seung-Ki
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2014, 13 (06) : 650 - 657